Transradial PCI in acute coronary syndrome (ACS) and ST-segment elevation myocardial infarction (STEMI) patients also appears to be associated with lower mortality, although no unequivocal mechanistic link for this mortality reduction has been identified (3, 4) . Nevertheless, the negative long-term adverse effects of bleeding after PCI are well recognized, and the European guidelines for PCI have weighed in on the subject, giving radial access a Class I indication for ACS patients undergoing PCI (5) . 
